GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Terumo Corp (OTCPK:TRUMY) » Definitions » Short Percentage of Float

Terumo (Terumo) Short Percentage of Float


View and export this data going back to 2008. Start your Free Trial

What is Terumo Short Percentage of Float?

Short Percentage of Float is the percentage of shares shorted compared to the float.

Due to the license agreement change with our data vendor, Short Interest related data is no longer available on GuruFocus website.

Competitive Comparison of Terumo's Short Percentage of Float

For the Medical Instruments & Supplies subindustry, Terumo's Short Percentage of Float, along with its competitors' market caps and Short Percentage of Float data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Terumo's Short Percentage of Float Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Terumo's Short Percentage of Float distribution charts can be found below:

* The bar in red indicates where Terumo's Short Percentage of Float falls into.


Terumo (Terumo) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Terumo Corp (OTCPK:TRUMY) » Definitions » Short Percentage of Float
Comparable Companies
TSE:7733 TSE:6869 TSE:7747 TSE:7741 TSE:3360 TSE:7730 TSE:7716 TSE:8086 TSE:7780 TSE:7817 ISRG XPAR:EL BDX XSWX:ALC WST XSWX:STMN OCSE:COLO B RMD XPAR:DIM BAX
Traded in Other Exchanges
TRUMF:USA 4543:Japan TUO:Germany
Address
2-44-1 Hatagaya, Shibuya-ku, Tokyo, JPN, 151-0072
Website
https://www.terumo.com
Terumo Corp manufactures and sells medical products and equipment. The firm has three main businesses: blood management, cardiac and vascular, and general hospital. The cardiac and vascular business generates the largest proportion of revenue and sells cardiac and endovascular interventional therapies, cardiovascular surgical systems, neurovascular products, and vascular graft products. The general hospital business includes diabetes management, consumer healthcare, drug and device technologies, and general hospital products. The blood management business sells blood component, therapeutic apheresis, and cellular technologies. Terumo generates the majority of its revenue in Asia, with Japan contributing the largest proportion of Asian revenue.